scispace - formally typeset
P

Philippe Desmarais

Researcher at Université de Montréal

Publications -  19
Citations -  296

Philippe Desmarais is an academic researcher from Université de Montréal. The author has contributed to research in topics: Medicine & Dementia. The author has an hindex of 7, co-authored 14 publications receiving 134 citations.

Papers
More filters
Journal ArticleDOI

The Interplay Between Post-traumatic Stress Disorder and Dementia: A Systematic Review.

TL;DR: Current evidence suggests that PTSD and dementia have a bidirectional relationship: PTSD increases the risk for late-onset dementia and dementia increases therisk for delayed-onsets PTSD in those who experienced a significant trauma earlier in life.
Journal ArticleDOI

Health Heterogeneity in Older Adults: Exploration in the Canadian Longitudinal Study on Aging

TL;DR: Heterogeneity at different ages across health characteristics is examined to describe variation and trends and the comparative importance of between‐age versus within‐age heterogeneity is investigated.
Journal ArticleDOI

Evolution of Age and Female Representation in the Most-Cited Randomized Controlled Trials of Cardiology of the Last 20 Years

TL;DR: Although age and female representation in the most influential randomized controlled trials in cardiology of the last 20 years to population prevalence increased over time, modest trends are unlikely to resolve the persistently wide gaps with actual populational prevalence.
Journal ArticleDOI

Cognitive and psychiatric symptoms in genetically determined Parkinson's disease: a systematic review.

TL;DR: Cognitive impairment was reported in all monogenic PD forms with variable rates and co‐occurrence of cognitive decline with visual hallucinations was evidenced, and widespread accumulation of Lewy bodies, distinctive of SNCA, PINK1 and DJ1 mutations, results in higher rates of cognitive impairment.
Journal ArticleDOI

Quetiapine for Psychosis in Parkinson Disease and Neurodegenerative Parkinsonian Disorders: A Systematic Review.

TL;DR: Although not causing any motor deterioration, quetiapine failed to significantly reduce psychotic symptoms compared to placebo when objectively assessed on the Brief Psychotic Rating Scale, the most frequently reported scale in these studies.